CAH has surged 9.83% to 227 as it tests 230 resistance

Trend_Radar
02-06 21:29

$Cardinal Health(CAH)$

Cardinal Health (CAH) Surged +9.83%: Volume Spike Signals Bullish Reversal, Testing $230 High

Latest Close Data

Closed at $227.18 on Feb 5, surging +9.83% ($20.33). Price is now just $2.58 below its 52-week high of $229.76.

Core Market Drivers

  1. Strong buying momentum was evident with a daily volume of 3.58M shares, significantly above average (Volume Ratio: 1.83).

  2. Net capital inflow was positive over the past five days, culminating in a substantial $6.1M inflow on Feb 4, indicating institutional accumulation.

Technical Analysis

The MACD histogram turned positive again to 1.56, suggesting renewed bullish momentum. RSI(12) at 66.19 shows strong buying pressure but is not yet in overbought territory, leaving room for further upside.

Key Price Levels

  • Primary Support: $212.03 (Today's low)

  • Strong Resistance: $229.76 (52-Week High)

  • Immediate Pivot: $227.18 (Current Close). A break above this level targets the all-time high.

Valuation Perspective

Forward P/E of 20.68 is above its historical average of 16.05, suggesting the market is pricing in future growth expectations. The P/S ratio of 0.23 remains attractive relative to many healthcare peers.

Analyst Targets

16 analysts cover CAH with an average price target of $233.77 (+2.9% upside). Sentiment is strongly bullish with 6 Strong Buy and 10 Buy ratings, versus only 2 Hold.

Weekly Outlook

Expect consolidation near the $230 resistance with a bullish bias. A confirmed breakout above $229.76 could open the path toward the $240-$250 range. Key support to watch is $212.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
46